InnoCan Pharma
Biotech-Innovation auf FDA-Kurs!
Anzeige
LORD ABBETT SEC/FOCUSED LARGE CAP V Chart: Profi-Chart ISIN: US54400B8019
Chart LORD ABBETT SEC/FOCUSED LARGE CAP V Fonds
16,50 USD
-2,65 %-0,45
26. Feb 2021,
Nasdaq